Comparative Pharmacology
Head-to-head clinical analysis: NUTRESTORE versus STILBESTROL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NUTRESTORE versus STILBESTROL.
NUTRESTORE vs STILBESTROL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
NUTRESTORE is a medical food containing L-citrulline, L-ornithine, and other amino acids; its mechanism is not fully characterized but is hypothesized to enhance the urea cycle and reduce ammonia levels by providing substrates for ureagenesis, thereby improving nitrogen disposal in patients with urea cycle disorders or hyperammonemia.
Synthetic nonsteroidal estrogen that acts by binding to estrogen receptors (ERα and ERβ), leading to translocation to the nucleus, modulation of gene transcription, and promotion of estrogenic effects in target tissues.
One capsule (500 mg) orally three times daily.
0.5 to 2 mg orally once daily; or 25 mg intramuscularly once daily for 5 days; for prostate cancer: 1 to 3 mg orally once daily.
None Documented
None Documented
Clinical Note
moderateDiethylstilbestrol + Digoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digoxin."
Clinical Note
moderateDiethylstilbestrol + Digitoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digitoxin."
Clinical Note
moderateDiethylstilbestrol + Deslanoside
"Diethylstilbestrol may decrease the cardiotoxic activities of Deslanoside."
Clinical Note
moderateDiethylstilbestrol + Acetyldigitoxin
Terminal elimination half-life: 18-24 hours. Steady-state reached after 4-5 days. Clinical context: Allows once-daily dosing; prolonged in renal impairment.
Terminal elimination half-life is approximately 24-48 hours, with a prolonged phase due to enterohepatic recirculation; requires dosing adjustment in hepatic impairment.
Renal: 50-70% unchanged; biliary/fecal: 20-30% as metabolites; 5-10% in feces as parent drug.
Renal excretion of glucuronide and sulfate conjugates accounts for approximately 60-80% of an administered dose; biliary/fecal excretion accounts for 15-30%; less than 5% is excreted unchanged in urine.
Category C
Category C
Estrogen
Estrogen
"Diethylstilbestrol may decrease the cardiotoxic activities of Acetyldigitoxin."